All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

HLA-G 5'URR regulatory polymorphisms are associated with the risk of developing gliomas

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00669806%3A_____%2F23%3A10443635" target="_blank" >RIV/00669806:_____/23:10443635 - isvavai.cz</a>

  • Alternative codes found

    RIV/00216208:11140/23:10443635

  • Result on the web

    <a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=eh-MEy3S1J" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=eh-MEy3S1J</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1080/00207454.2021.1922401" target="_blank" >10.1080/00207454.2021.1922401</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    HLA-G 5'URR regulatory polymorphisms are associated with the risk of developing gliomas

  • Original language description

    Background: Human leukocyte antigen G (HLA-G) belongs to non-classical MHC class I molecules that is involved in the suppression of immune response. As HLA-G plays important role in the maintenance of fetal tolerance, its overexpression has been associated with tumor progression. For the regulation of HLA-G levels, genetic variants within the 5&apos; upstream regulatory region (5&apos;URR) are of crucial importance. Our study aimed to analyze the association between 16 HLA-G 5&apos;URR variants, sHLA-G level and clinical variables in glioma patients. Methods: We investigated 59 patients with gliomas (mean age 54.70+-15.10 years) and 131 healthy controls (mean age 41.45+-9.75 years). Patient&apos;s blood was obtained on the day of surgical treatment. The HLA-G 5&apos;URR polymorphisms were typed by direct sequencing and the plasma level of sHLA-G assessed by ELISA. Results: Haploblock within HLA-G 5&apos;URR consisting of -762T, -716G, -689G, -666T, -633A, followed by -486C and -201A alleles were significantly more frequent in patients with gliomas than in the controls (p&lt;0.05). No correlation of HLA-G 5&apos;URR variants with sHLA-G plasma level was found. Analysis of HLA-G 5&apos;URR variants with main clinical variables in patients with grade IV gliomas revealed that haploblock carriers of -762CT, -716TG, -689AG, -666GT, -633GA, -486AC, -477GC, -201GA followed by -369AC carriers tend to have lower age at onset as compared to other genotype carriers (p=0.04). Conclusion: Our results suggest genetic association of HLA-G 5&apos;URR variants with risk of developing gliomas and possible contribution of HLA-G to disease pathology

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30109 - Pathology

Result continuities

  • Project

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2023

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    International Journal of Neuroscience

  • ISSN

    0020-7454

  • e-ISSN

    1563-5279

  • Volume of the periodical

    133

  • Issue of the periodical within the volume

    4

  • Country of publishing house

    GB - UNITED KINGDOM

  • Number of pages

    10

  • Pages from-to

    365-374

  • UT code for WoS article

    000701573100001

  • EID of the result in the Scopus database

    2-s2.0-85116075237